Last Price
260.399
Today's Change
+1.73 (0.66%)
Day's Change
255.72 - 260.399
Trading Volume
270,089
Market Cap
126 Billion
Shares Outstanding
484 Million
Avg Volume
712,952
Avg Price (50 Days)
274.55
Avg Price (200 Days)
288.74
PE Ratio
30.31
EPS
8.59
Earnings Announcement
19-Aug-2025
Previous Close
258.67
Open
256.75
Day's Range
255.72 - 260.355
Year Range
253.04 - 313.55
Trading Volume
271,001
1 Day Change
0.65%
5 Day Change
1.80%
1 Month Change
-3.57%
3 Month Change
-5.83%
6 Month Change
-15.88%
Ytd Change
-7.41%
1 Year Change
-8.76%
3 Year Change
-3.17%
5 Year Change
-20.00%
10 Year Change
188.45%
Max Change
31394.43%
No result.
Sector: Healthcare - Healthcare
Industry: Biotechnology
Description:
CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.